Latest Insider Transactions at Natures Sunshine Products Inc (NATR)
This section provides a real-time view of insider transactions for Natures Sunshine Products Inc (NATR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NATURES SUNSHINE PRODUCTS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NATURES SUNSHINE PRODUCTS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 18
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.76%
|
$100,000
$20.45 P/Share
|
|
Nov 17
2025
|
Daniel C Norman EVP & President, Asia |
SELL
Bona fide gift
|
Direct |
3,571
-5.36%
|
$71,420
$20.79 P/Share
|
|
Nov 14
2025
|
Nathan G Brower EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
3,800
-7.52%
|
$76,000
$20.81 P/Share
|
|
Nov 12
2025
|
Daniel C Norman EVP & President, Asia |
SELL
Open market or private sale
|
Direct |
8,884
-11.76%
|
$177,680
$20.46 P/Share
|
|
Nov 04
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
614
-0.6%
|
$7,982
$13.75 P/Share
|
|
Nov 04
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,796
+1.7%
|
-
|
|
Nov 04
2025
|
Leslie Shane Jones EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,756
-1.59%
|
$22,828
$13.75 P/Share
|
|
Nov 04
2025
|
Leslie Shane Jones EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,004
+3.5%
|
-
|
|
Nov 04
2025
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-0.97%
|
$12,805
$13.75 P/Share
|
|
Nov 04
2025
|
Nathan G Brower EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,243
+3.09%
|
-
|
|
Nov 04
2025
|
Martin A. Gonzalez EVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,673
-1.2%
|
$21,749
$13.75 P/Share
|
|
Nov 04
2025
|
Martin A. Gonzalez EVP, Global Supply Chain |
BUY
Exercise of conversion of derivative security
|
Direct |
5,795
+4.01%
|
-
|
|
Nov 04
2025
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,134
-0.57%
|
$14,742
$13.75 P/Share
|
|
Nov 04
2025
|
Bryant J Yates EVP & President, Europe |
BUY
Exercise of conversion of derivative security
|
Direct |
3,940
+1.92%
|
-
|
|
Nov 04
2025
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
1,138
-0.75%
|
$14,794
$13.75 P/Share
|
|
Nov 04
2025
|
Daniel C Norman EVP & President, Asia |
BUY
Exercise of conversion of derivative security
|
Direct |
3,940
+2.53%
|
-
|
|
Nov 04
2025
|
Kenneth G. Romanzi Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
102,881
+50.0%
|
$1,440,334
$14.58 P/Share
|
|
Sep 26
2025
|
Kevin Gregory Fuller Global Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,261
-5.21%
|
$18,915
$15.89 P/Share
|
|
Aug 29
2025
|
Bryant J Yates EVP & President, Europe |
SELL
Open market or private sale
|
Direct |
4,672
-4.57%
|
$74,752
$16.71 P/Share
|
|
Aug 26
2025
|
Bryant J Yates EVP & President, Europe |
SELL
Open market or private sale
|
Direct |
5,000
-4.67%
|
$80,000
$16.77 P/Share
|
|
Aug 13
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
5,000
-9.08%
|
$80,000
$16.51 P/Share
|
|
Aug 13
2025
|
Nathan G Brower EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
9,996
-17.15%
|
$159,936
$16.54 P/Share
|
|
Jul 21
2025
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,491
-2.49%
|
$20,874
$14.8 P/Share
|
|
Jul 21
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
341
-0.62%
|
$4,774
$14.8 P/Share
|
|
Jul 21
2025
|
Tracee Comstock VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
1,235
-1.88%
|
$17,290
$14.8 P/Share
|
|
Jul 21
2025
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
1,703
-2.29%
|
$23,842
$14.8 P/Share
|
|
Jul 21
2025
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,302
-1.68%
|
$130,228
$14.8 P/Share
|
|
Jul 21
2025
|
Martin A. Gonzalez EVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,781
-5.46%
|
$52,934
$14.8 P/Share
|
|
Jul 21
2025
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,738
-1.6%
|
$24,332
$14.8 P/Share
|
|
Jun 27
2025
|
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. |
SELL
Open market or private sale
|
Indirect |
2,854,607
-100.0%
|
$31,400,677
$11.46 P/Share
|
|
May 05
2025
|
Steven J. Fasching Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+42.4%
|
-
|
|
May 05
2025
|
Heidi Wissmiller Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+17.71%
|
-
|
|
May 05
2025
|
Rong Yang Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+20.92%
|
-
|
|
May 05
2025
|
Katie May Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+45.03%
|
-
|
|
May 05
2025
|
Curtis Kopf Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+21.09%
|
-
|
|
May 05
2025
|
Tess Roering Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+21.09%
|
-
|
|
May 05
2025
|
Robert D Straus Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+13.33%
|
-
|
|
Mar 11
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
833
-1.48%
|
$11,662
$14.5 P/Share
|
|
Mar 11
2025
|
Leslie Shane Jones EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,343
-2.16%
|
$32,802
$14.5 P/Share
|
|
Mar 11
2025
|
Nathan G Brower EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
991
-1.63%
|
$13,874
$14.5 P/Share
|
|
Mar 11
2025
|
Kevin R. Herbert EVP & President, North America |
SELL
Payment of exercise price or tax liability
|
Direct |
980
-2.25%
|
$13,720
$14.5 P/Share
|
|
Mar 11
2025
|
Terrence Moorehead Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,180
-1.11%
|
$86,520
$14.5 P/Share
|
|
Mar 11
2025
|
Martin A. Gonzalez EVP, Global Supply Chain |
SELL
Payment of exercise price or tax liability
|
Direct |
1,290
-1.83%
|
$18,060
$14.5 P/Share
|
|
Mar 11
2025
|
Daniel C Norman EVP & President, Asia |
SELL
Payment of exercise price or tax liability
|
Direct |
1,406
-1.85%
|
$19,684
$14.5 P/Share
|
|
Mar 11
2025
|
Tracee Comstock VP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
834
-1.25%
|
$11,676
$14.5 P/Share
|
|
Mar 11
2025
|
Bryant J Yates EVP & President, Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,201
-1.09%
|
$16,814
$14.5 P/Share
|
|
Mar 10
2025
|
Jonathan David Lanoy SVP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,882
+13.64%
|
$124,348
$14.74 P/Share
|
|
Mar 10
2025
|
Leslie Shane Jones EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,474
+15.2%
|
$272,636
$14.74 P/Share
|
|
Mar 10
2025
|
Nathan G Brower EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
11,966
+16.45%
|
$167,524
$14.74 P/Share
|
|
Mar 10
2025
|
Kevin R. Herbert EVP & President, North America |
BUY
Grant, award, or other acquisition
|
Direct |
11,760
+21.24%
|
$164,640
$14.74 P/Share
|